DETERMINATION OF THE PHOSPHATE CONTENT OF PURIFIED PROTEINSHASEGAWA H; PARNIAK M; KAUFMAN S et al.1982; ANAL. BIOCHEM.; ISSN 0003-2697; USA; DA. 1982; VOL. 120; NO 2; PP. 360-364; BIBL. 15 REF.Article

Enhancement of glycogen concentrations in primary cultures of rat hepatocytes exposed to glucose and fructosePARNIAK, M. A; KALANT, N.Biochemical journal (London. 1906). 1988, Vol 251, Num 3, pp 795-802, issn 0006-2936, 8 p.Article

ON THE PHOSPHATE CONTENT OF RAT LIVER PHENYLALANINE HYDROXYLASE PURIFIED BY HYDROPHOBIC CHROMATOGRAPHYPARNIAK M; HASEGAWA H; WILGUS H et al.1981; BIOCHEM. BIOPHYS. RES. COMMUN.; ISSN 0006-291X; USA; DA. 1981; VOL. 99; NO 2; PP. 707-714; BIBL. 11 REF.Article

Non-enzymic glycation of collagen inhibits binding of oxidized low-density lipoproteinKALANT, N; MCCORMICK, S; PARNIAK, M. A et al.Biochemical journal (London. 1984). 1993, Vol 293, pp 661-666, issn 0264-6021, 3Article

Compartmentation of glucose 6-phosphate in hepatocytesKALANT, N; PARNIAK, M; LEMIEUX, M et al.Biochemical journal (London. 1906). 1987, Vol 248, Num 3, pp 927-931, issn 0006-2936Article

Effect of alkaline pH on the activity of rat liver phenylalanine hydroxylasePARNIAK, M. A; DAVIS, M. D; KAUFMAN, S et al.The Journal of biological chemistry (Print). 1988, Vol 263, Num 3, pp 1223-1230, issn 0021-9258Article

The interaction of aromatic amino acids with rat liver phenylalanine hydroxylasePHILLIPS, R. S; PARNIAK, M. A; KAUFMAN, S et al.The Journal of biological chemistry (Print). 1984, Vol 259, Num 1, pp 271-277, issn 0021-9258Article

Isolation and fractionation of retroviral tRNAsJIANG, M; PARNIAK, M. A; KLEIMAN, L et al.Journal of virological methods. 1992, Vol 38, Num 2, pp 205-213, issn 0166-0934Article

Studies on the primary structure of rat liver phenylalanine hydroxylaseIWAKI, M; PARNIAK, M. A; KAUFMAN, S et al.Biochemical and biophysical research communications (Print). 1985, Vol 126, Num 2, pp 922-932, issn 0006-291XArticle

Inhibition of carboxypeptidase a by N-(4-t-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazoneLANTHIER, C. M; PARNIAK, M. A; DMITRIENKO, G. I et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 12, pp 1557-1562, issn 0960-894XArticle

The thiocarboxanilide nonnucleoside inhibitor UC781 restores antiviral activity of 3'-azido-3'-deoxythymidine (AZT) against azt-resistant human immunodeficiency virus type 1BORKOW, G; ARION, D; WAINBERG, M. A et al.Antimicrobial agents and chemotherapy. 1999, Vol 43, Num 2, pp 259-263, issn 0066-4804Article

Generation and characterization of murine monoclonal antibodies reactive against N-terminal and other regions of HIV-1 reverse transcriptaseXUGUANG LI; AMANDORON, E; WAINBERG, M. A et al.Journal of medical virology. 1993, Vol 39, Num 3, pp 251-259, issn 0146-6615Article

Mechanism of inhibition of HIV-1 infection in vitro by purified extract of Prunella vulgarisXIAO-JIAN YAO; WAINBERG, M. A; PARNIAK, M. A et al.Virology (New York, NY). 1992, Vol 187, Num 1, pp 56-62, issn 0042-6822Article

Novel mutation in the human immunodeficiency virus type 1 reverse transcriptase gene that encodes cross-resistance to 2',3'-dideoxyinosine and 2',3'-dideoxycytidineGU, Z; GAO, Q; LI, X et al.Journal of virology. 1992, Vol 66, Num 12, pp 7128-7135, issn 0022-538XArticle

Incorporation of tRNA into normal and mutant HIV-1KLEIMAN, L; CAUDRY, S; BOULERICE, F et al.Biochemical and biophysical research communications (Print). 1991, Vol 174, Num 3, pp 1272-1280, issn 0006-291X, 9 p.Article

Variable tRNA content in HIV-1_IIIBJIANG, M; MAK, J; WAINBERG, M. A et al.Biochemical and biophysical research communications (Print). 1992, Vol 185, Num 3, pp 1005-1015, issn 0006-291XArticle

Missense mutations in the phenylalanine hydroxylase gene (PAH) can cause accelerated proteolytic turnover of PAH enzyme : A mechanism underlying phenylketonuriaWATERS, P. J; PARNIAK, M. A; AKERMAN, B. R et al.Journal of inherited metabolic disease. 1999, Vol 22, Num 3, pp 208-212, issn 0141-8955Article

Comparison of deoxyoligonucleotide and tRNA ^Lys-3 as primers in an endogenous human immunodeficiency virus-1 in vitro reverse transcription/template-switching reactionARTS, E. J; XUGUANG LI; ZHENGXIAN GU et al.The Journal of biological chemistry (Print). 1994, Vol 269, Num 20, pp 14672-14680, issn 0021-9258Article

Biological comparison of wild-type and zidovudine-resistant isolates of human immunodeficiency virus type 1 from the same subjects : susceptibility and resistance to other drugsROOKE, R; PARNIAK, M. A; TREMBLAY, M et al.Antimicrobial agents and chemotherapy. 1991, Vol 35, Num 5, pp 988-991, issn 0066-4804, 4 p.Article

Preclinical studies on thiocarboxanilide UC-781 as a virucidal agentBALZARINI, J; NAESENS, L; VERBEKEN, E et al.AIDS (London). 1998, Vol 12, Num 10, pp 1129-1138, issn 0269-9370Article

Preclinical safety assessments of UC781 anti-human immunodeficiency virus topical microbicide formulationsPATTON, D. L; COSGROVE SWEENEY, Y. T; BALKUS, J. E et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 5, pp 1608-1615, issn 0066-4804, 8 p.Article

Enhanced fidelity of 3TC-selected mutant HIV-1 reverse transcriptaseWAINBERG, M. A; DROSOPOULOIS, W. C; CASTRIOTA, G et al.Science (Washington, D.C.). 1996, Vol 271, Num 5253, pp 1282-1285, issn 0036-8075Article